198 related articles for article (PubMed ID: 35018513)
1. Stabilization of SETD3 by deubiquitinase USP27 enhances cell proliferation and hepatocellular carcinoma progression.
Zou T; Wang Y; Dong L; Che T; Zhao H; Yan X; Lin Z
Cell Mol Life Sci; 2022 Jan; 79(1):70. PubMed ID: 35018513
[TBL] [Abstract][Full Text] [Related]
2. USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis.
Dong L; Yu L; Bai C; Liu L; Long H; Shi L; Lin Z
Oncogene; 2018 May; 37(20):2702-2713. PubMed ID: 29497124
[TBL] [Abstract][Full Text] [Related]
3. SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma.
Xu L; Wang P; Feng X; Tang J; Li L; Zheng X; Zhang J; Hu Y; Lan T; Yuan K; Zhang Y; Ren S; Hao X; Zhang M; Xu M
Clin Sci (Lond); 2019 Oct; 133(20):2085-2105. PubMed ID: 31654063
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis.
Cheng X; Hao Y; Shu W; Zhao M; Zhao C; Wu Y; Peng X; Yao P; Xiao D; Qing G; Pan Z; Yin L; Hu D; Du HN
J Biol Chem; 2017 Jun; 292(22):9022-9033. PubMed ID: 28442573
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of ubiquitin-specific peptidase 13 inhibits cell growth of hepatocellular carcinoma by reducing c-Myc expression.
Huang J; Gu ZL; Chen W; Xu YY; Chen M
Kaohsiung J Med Sci; 2020 Aug; 36(8):615-621. PubMed ID: 32255563
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination.
Li T; Yan B; Ma Y; Weng J; Yang S; Zhao N; Wang X; Sun X
Cell Death Dis; 2018 Feb; 9(2):148. PubMed ID: 29396555
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Ubiquitin-Specific Protease15 (USP15) Promotes Tumor Growth and Inhibits Apoptosis and Correlated With Poor Disease-Free Survival in Hepatocellular Carcinoma.
Yao XQ; Li L; Piao LZ; Zhang GJ; Huang XZ; Wang Y; Liang ZL
Technol Cancer Res Treat; 2020; 19():1533033820967455. PubMed ID: 33267707
[TBL] [Abstract][Full Text] [Related]
9. The deubiquitinase OTUD3 stabilizes ACTN4 to drive growth and metastasis of hepatocellular carcinoma.
Xie P; Chen Y; Zhang H; Zhou G; Chao Q; Wang J; Liu Y; Fang J; Xie J; Zhen J; Wang Z; Hao L; Huang D
Aging (Albany NY); 2021 Aug; 13(15):19317-19338. PubMed ID: 34380780
[TBL] [Abstract][Full Text] [Related]
10. SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells.
Hassan N; Rutsch N; Győrffy B; Espinoza-Sánchez NA; Götte M
Sci Rep; 2020 Feb; 10(1):2262. PubMed ID: 32042016
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus mediated silencing of ubiquitin specific peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro.
Pan Z; Pan H; Zhang J; Yang Y; Liu H; Yang Y; Huang G; Ni J; Huang J; Zhou W
Biol Res; 2015 Mar; 48(1):18. PubMed ID: 25889525
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2.
Lv J; Zhang S; Wu H; Lu J; Lu Y; Wang F; Zhao W; Zhan P; Lu J; Fang Q; Xie C; Yin Z
Cancer Lett; 2020 Jan; 469():22-34. PubMed ID: 31634528
[TBL] [Abstract][Full Text] [Related]
13. SETD3 reduces KLC4 expression to improve the sensitization of cervical cancer cell to radiotherapy.
Li Q; Zhang Y; Jiang Q
Biochem Biophys Res Commun; 2019 Aug; 516(3):619-625. PubMed ID: 31235251
[TBL] [Abstract][Full Text] [Related]
14. MiR-15b and miR-322 inhibit SETD3 expression to repress muscle cell differentiation.
Zhao MJ; Xie J; Shu WJ; Wang HY; Bi J; Jiang W; Du HN
Cell Death Dis; 2019 Feb; 10(3):183. PubMed ID: 30796205
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of ubiquitin-specific protease 1 reveals its importance in hepatocellular carcinoma.
Zhao Y; Xue C; Xie Z; Ouyang X; Li L
Cell Prolif; 2020 Oct; 53(10):e12908. PubMed ID: 32951278
[TBL] [Abstract][Full Text] [Related]
16. USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells.
Liao Y; Shao Z; Liu Y; Xia X; Deng Y; Yu C; Sun W; Kong W; He X; Liu F; Guo Z; Chen G; Tang D; Gan H; Liu J; Huang H
J Exp Clin Cancer Res; 2021 Jun; 40(1):201. PubMed ID: 34154657
[TBL] [Abstract][Full Text] [Related]
17. The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation.
Wu W; Wu W; Zhou Y; Yang Q; Zhuang S; Zhong C; Li W; Li A; Zhao W; Yin X; Zu X; Chak-Lui Wong C; Yin D; Hu K; Cai M
J Biol Chem; 2024 Mar; 300(3):105671. PubMed ID: 38272222
[TBL] [Abstract][Full Text] [Related]
18. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
[TBL] [Abstract][Full Text] [Related]
19. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
[TBL] [Abstract][Full Text] [Related]
20. A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4.
Jiang X; Wang G; Liu Y; Mei C; Yao Y; Wu X; Chen X; Ma W; Li K; Zhang Z; Yuan Y
Cancer Lett; 2021 Feb; 499():109-121. PubMed ID: 33259899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]